Episode 41: AI for Clinical Trials with Dr Félix Balazard, Director of Optimized Development Solutions, Owkin

AI has the potential to revolutionize clinical trials in many ways. It could make the development of new treatments faster, safer, cheaper and more personalised. One company in this space is Owkin, a unicorn startup based in Paris. With me is Dr Félix Balazard, Director of Optimized Development Solutions.